{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:07:47Z","timestamp":1788937667953,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-026-05029-6","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:01:35Z","timestamp":1788937295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fractional CO\u2082 vaginal laser therapy for genitourinary syndrome of menopause in breast cancer survivors: a scoping review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-5001","authenticated-orcid":false,"given":"Sine","family":"Jacobsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Kristine","family":"Eliasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Kj\u00e6r","family":"Stokvad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"5029_CR1","unstructured":"World Health Organization Breast Cancer 2025 [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"issue":"3","key":"5029_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5029_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.mcna.2022.10.017","volume":"107","author":"S Cox","year":"2023","unstructured":"Cox S, Nasseri R, Rubin RS, Santiago-Lastra Y (2023) Genitourinary syndrome of menopause. Med Clin North Am 107(2):357\u2013369","journal-title":"Med Clin North Am"},{"issue":"2","key":"5029_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","volume":"20","author":"J Baumgart","year":"2013","unstructured":"Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 20(2):162\u2013168","journal-title":"Menopause"},{"issue":"5","key":"5029_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cncr.22485","volume":"109","author":"TI Barron","year":"2007","unstructured":"Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ (2007) Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109(5):832\u2013839","journal-title":"Cancer"},{"key":"5029_CR6","doi-asserted-by":"crossref","unstructured":"Kinslow CJ, Tang A, Chaudhary KR, Cheng SK (2022) Prevalence of estrogen receptor alpha (ESR1) somatic mutations in breast cancer. JNCI Cancer Spectr 6(5)","DOI":"10.1093\/jncics\/pkac060"},{"issue":"2","key":"5029_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/lsm.22637","volume":"49","author":"Y Tadir","year":"2017","unstructured":"Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A et al (2017) Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies. Lasers Surg Med 49(2):137\u2013159","journal-title":"Lasers Surg Med"},{"issue":"11","key":"5029_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2217\/cer-2021-0281","volume":"11","author":"R Zipper","year":"2022","unstructured":"Zipper R, Lamvu G (2022) Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here. J Comp Eff Res 11(11):843\u2013851","journal-title":"J Comp Eff Res"},{"issue":"4","key":"5029_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00404-020-05868-w","volume":"303","author":"T Sindou-Faurie","year":"2021","unstructured":"Sindou-Faurie T, Louis-Vahdat C, Oueld Es Cheikh E, Canlorbe G, Mergui JL, Uzan C et al (2021) Evaluation of the efficacy of fractional CO2 laser in the treatment of vulvar and vaginal menopausal symptoms. Arch Gynecol Obstet 303(4):955\u2013963","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"5029_CR10","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.jogoh.2019.07.010","volume":"49","author":"J Marin","year":"2020","unstructured":"Marin J, Lipa G, Dunet E (2020) The results of new low dose fractional CO2 Laser - A prospective clinical study in France. J Gynecol Obstet Hum Reprod 49(3):101614","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"5029_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/asj\/sjy087","volume":"39","author":"JB Samuels","year":"2019","unstructured":"Samuels JB, Garcia MA (2019) Treatment to external labia and vaginal canal with CO2 laser for symptoms of vulvovaginal atrophy in postmenopausal women. Aesthet Surg J 39(1):83\u201393","journal-title":"Aesthet Surg J"},{"issue":"7","key":"5029_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/GME.0000000000000839","volume":"24","author":"ER Sokol","year":"2017","unstructured":"Sokol ER, Karram MM (2017) Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause 24(7):810\u2013814","journal-title":"Menopause"},{"key":"5029_CR13","unstructured":"FDA. FDA Warns Against Use of Energy-Based Devices to Perform Vaginal \u2019Rejuvenation\u2019 or Vaginal Cosmetic Procedures: FDA Safety Communication (2019) . Available at: https:\/\/www.fda.gov\/medical-devices\/safety-communications\/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic"},{"key":"5029_CR14","doi-asserted-by":"publisher","first-page":"108155","DOI":"10.1016\/j.maturitas.2024.108155","volume":"191","author":"GC Cantarelli","year":"2025","unstructured":"Cantarelli GC, Bianchi-Ferraro A, Dedonatto C, Fernandes MFR, Vanzin RB, Dardes RCM et al (2025) Clinical and histomorphometric evaluation of the vagina following treatment with CO(2) laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy. Maturitas 191:108155","journal-title":"Maturitas"},{"issue":"12","key":"5029_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/GME.0000000000002274","volume":"30","author":"MFR Fernandes","year":"2023","unstructured":"Fernandes MFR, Bianchi-Ferraro A, Sartori MGF, Di J\u00e1rmy ZIK, Cantarelli GC, Dedonatto C et al (2023) CO 2 laser, radiofrequency, and promestriene in the treatment of genitourinary syndrome of menopause in breast cancer survivors: a histomorphometric evaluation of the vulvar vestibule. Menopause 30(12):1213\u20131220","journal-title":"Menopause"},{"key":"5029_CR16","doi-asserted-by":"crossref","unstructured":"Jaber S, Levin G, Ram-Weiner M, Lev-Sagie A (2025) CO(2) Laser therapy for genitourinary syndrome of menopause in women with breast cancer: a randomized, sham-controlled trial. Cancers (Basel). ;17(7)","DOI":"10.3390\/cancers17071241"},{"issue":"2","key":"5029_CR17","doi-asserted-by":"publisher","first-page":"e2255697","DOI":"10.1001\/jamanetworkopen.2022.55697","volume":"6","author":"E Mension","year":"2023","unstructured":"Mension E, Alonso I, Angl\u00e8s-Acedo S, Ros C, Otero J, Villarino \u00c1 et al (2023) Effect of fractional carbon dioxide vs sham laser on sexual function in survivors of breast cancer receiving aromatase inhibitors for genitourinary syndrome of menopause: the LIGHT randomized clinical trial. JAMA Netw Open 6(2):e2255697","journal-title":"JAMA Netw Open"},{"issue":"7","key":"5029_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467\u2013473","journal-title":"Ann Intern Med"},{"issue":"5","key":"5029_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s10103-018-2471-3","volume":"33","author":"A Becorpi","year":"2018","unstructured":"Becorpi A, Campisciano G, Zanotta N, Tredici Z, Guaschino S, Petraglia F et al (2018) Fractional CO(2) laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects. Lasers Med Sci 33(5):1047\u20131054","journal-title":"Lasers Med Sci"},{"issue":"4","key":"5029_CR20","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.anplas.2020.05.002","volume":"65","author":"B Hersant","year":"2020","unstructured":"Hersant B, Werkoff G, Sawan D, Sidahmed-Mezi M, Bosc R, La Padula S et al (2020) Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial. Ann Chir Plast Esthet 65(4):e23\u2013e31","journal-title":"Ann Chir Plast Esthet"},{"issue":"4","key":"5029_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00404-023-07323-y","volume":"309","author":"A Lami","year":"2024","unstructured":"Lami A, Alvisi S, Baldassarre M, Zanella S, Amati V, Seracchioli R et al (2024) Safety and efficacy of non-ablative CO(2) laser treatment of vulvo-vaginal atrophy in women with history of breast cancer. Arch Gynecol Obstet 309(4):1575\u20131583","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"5029_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-019-05384-9","volume":"178","author":"A Pearson","year":"2019","unstructured":"Pearson A, Booker A, Tio M, Marx G, Vaginal (2019) CO(2) laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study. Breast Cancer Res Treat 178(1):135\u2013140","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5029_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","volume":"294","author":"A Pieralli","year":"2016","unstructured":"Pieralli A, Fallani MG, Becorpi A, Bianchi C, Corioni S, Longinotti M et al (2016) Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet 294(4):841\u2013846","journal-title":"Arch Gynecol Obstet"},{"key":"5029_CR24","doi-asserted-by":"crossref","unstructured":"Quick AM, Hundley A, Evans C, Stephens JA, Ramaswamy B, Reinbolt RE et al (2022) Long-term follow-up of fractional CO(2) laser therapy for genitourinary syndrome of menopause in breast cancer survivors. J Clin Med. ;11(3)","DOI":"10.3390\/jcm11030774"},{"issue":"6","key":"5029_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/GME.0000000000001738","volume":"28","author":"AM Quick","year":"2021","unstructured":"Quick AM, Zvinovski F, Hudson C, Hundley A, Evans C, Stephens JA et al (2021) Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy. Menopause 28(6):642\u2013649","journal-title":"Menopause"},{"issue":"8","key":"5029_CR26","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00520-019-05211-3","volume":"28","author":"AM Quick","year":"2020","unstructured":"Quick AM, Zvinovski F, Hudson C, Hundley A, Evans C, Suresh A et al (2020) Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. Support Care Cancer 28(8):3669\u20133677","journal-title":"Support Care Cancer"},{"issue":"4","key":"5029_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/13697137.2017.1319815","volume":"20","author":"GP Siliquini","year":"2017","unstructured":"Siliquini GP, BV VTE, F. B, and, Biglia N (2017) Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric 20(4):379\u2013384","journal-title":"Climacteric"},{"issue":"2","key":"5029_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-021-06226-3","volume":"188","author":"L Veron","year":"2021","unstructured":"Veron L, Wehrer D, Annerose-Z\u00e9phir G, Suciu V, Delaloge S, Pistilli B et al (2021) Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. Breast Cancer Res Treat 188(2):501\u2013509","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5029_CR29","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1016\/j.clbc.2021.01.006","volume":"21","author":"S Salvatore","year":"2021","unstructured":"Salvatore S, Nappi RE, Casiraghi A, Ruffolo AF, Degliuomini R, Parma M et al (2021) Microablative fractional CO(2) laser for vulvovaginal atrophy in women with a history of breast cancer: a pilot study at 4-week follow-up. Clin Breast Cancer 21(5):e539\u2013e46","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"5029_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/ijgc-2019-001028","volume":"30","author":"R Angioli","year":"2020","unstructured":"Angioli R, Stefano S, Filippini M, Pieralli A, Montera R, Plotti F et al (2020) Effectiveness of CO(2) laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study. Int J Gynecol Cancer 30(5):590\u2013595","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"5029_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/GME.0000000000001428","volume":"27","author":"M Filippini","year":"2020","unstructured":"Filippini M, Luvero D, Salvatore S, Pieralli A, Montera R, Plotti F et al (2020) Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause 27(1):43\u201349","journal-title":"Menopause"},{"issue":"5","key":"5029_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/GME.0000000000001727","volume":"28","author":"AN Gardner","year":"2021","unstructured":"Gardner AN, Aschkenazi SO (2021) The short-term efficacy and safety of fractional CO2 laser therapy for vulvovaginal symptoms in menopause, breast cancer, and lichen sclerosus. Menopause 28(5):511\u2013516","journal-title":"Menopause"},{"issue":"3","key":"5029_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/14764172.2018.1481510","volume":"21","author":"P Gittens","year":"2019","unstructured":"Gittens P, Mullen G (2019) The effects of fractional microablative CO(2) laser therapy on sexual function in postmenopausal women and women with a history of breast cancer treated with endocrine therapy. J Cosmet Laser Ther 21(3):127\u2013131","journal-title":"J Cosmet Laser Ther"},{"issue":"10","key":"5029_CR34","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/GME.0000000000000672","volume":"23","author":"T Pagano","year":"2016","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, De Placido S et al (2016) Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and\/or hormonal therapy for breast cancer: a retrospective study. Menopause 23(10):1108\u20131113","journal-title":"Menopause"},{"issue":"6","key":"5029_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/GME.0000000000001053","volume":"25","author":"T Pagano","year":"2018","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, Giuliano M et al (2018) Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause 25(6):657\u2013662","journal-title":"Menopause"},{"issue":"5","key":"5029_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/tbj.14211","volume":"27","author":"GP Siliquini","year":"2021","unstructured":"Siliquini GP, Bounous VE, Novara L, Giorgi M, Bert F, Biglia N (2021) Fractional CO\u2082 vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. Breast J 27(5):448\u2013455","journal-title":"Breast J"},{"issue":"3","key":"5029_CR37","doi-asserted-by":"publisher","first-page":"278e1","DOI":"10.1016\/j.ajog.2023.05.005","volume":"229","author":"FG Li","year":"2023","unstructured":"Li FG, Fuchs T, Deans R, McCormack L, Nesbitt-Hawes E, Abbott J et al (2023) Vaginal epithelial histology before and after fractional CO(2) laser in postmenopausal women: a double-blind, sham-controlled randomized trial. Am J Obstet Gynecol 229(3):278e1\u2013e9","journal-title":"Am J Obstet Gynecol"},{"key":"5029_CR38","doi-asserted-by":"crossref","unstructured":"L\u0151czi LL, Vlesk\u00f3 G, \u00c9li\u00e1s M, Turan C, Kajt\u00e1r P, T\u00f3th R et al (2024) Effect of vaginal laser and topical therapies on vulvovaginal atrophy symptoms in breast cancer patients: a systematic review and meta-analysis. J Clin Med 13(20)","DOI":"10.3390\/jcm13206131"},{"issue":"5","key":"5029_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/lsm.70027","volume":"57","author":"KST Ferreira","year":"2025","unstructured":"Ferreira KST, Guimar\u00e3es NS, de Oliveira GV (2025) Efficacy of erbium and CO(2) genital laser treatment on genitourinary syndrome in female patients after breast cancer: a scoping review. Lasers Surg Med 57(5):365\u2013372","journal-title":"Lasers Surg Med"},{"key":"5029_CR40","doi-asserted-by":"crossref","unstructured":"Serquiz N, Sarmento ACA, de Aquino ACQ, Almeida NR, Nobre ML, de Ara\u00fajo Santos Camargo JD et al (2025) Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial. Int J Gynaecol Obstet","DOI":"10.1002\/ijgo.70665"},{"issue":"3","key":"5029_CR41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/JU.0000000000004589","volume":"214","author":"MRAA Kaufman","year":"2025","unstructured":"Kaufman MRAA, Amin KA, Coffey M, Danan E, Faubion SS et al (2025) The AUA\/SUFU\/AUGS guideline on genitourinary syndrome of menopause. J Urol 214(3):242\u2013250. https:\/\/doi.org\/10.1097\/JU.0000000000004589","journal-title":"J Urol"},{"key":"5029_CR42","volume-title":"Menopause: identification and management. NICE guideline NG23","author":"National Institute for Health and Care Excellence","year":"2015","unstructured":"National Institute for Health and Care Excellence (2015) Menopause: identification and management. NICE guideline NG23. NICE, London. [updated 2026]. Recommendation 1.5.20: Vaginal laser treatment"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-05029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-05029-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-05029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:01:43Z","timestamp":1788937303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-05029-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5029"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-05029-6","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"220"}}